Physician

Roy Ho Hsin Chen, MD

According to 2025 Medicare claims, Roy Chen, MD (NPI: 1720248081) practices hematology/oncology in the Nassau County-Suffolk County, NY market, with the plurality of this provider's patient population coming from Suffolk, NY. This provider's primary affiliated billing organization is NORTH SHORE HEMATOLOGY ONCOLOGY ASSOCIATES PC (NPI: 1396794574; TIN: 112419534) and primary practice location at 11901-9999. Chen is affiliated with the ilumed, LLC (ACO ID: D0005) and Vytalize Health 9 ACO LLC (ACO ID: D0313), participating under the REACH model.

Chen's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,846 traditional Medicare patients, billed 280,638 HCPCS/CPT codes, and received $3,491,803 in Medicare payments. The top billing code was 80053 (Blood test, comprehensive group of blood chemicals). Part D data shows 2,162 prescription claims across 316 beneficiaries totaling $9,607,416 in drug costs, led by Aranesp (Darbepoetin Alfa In Polysorbat). DME data shows 208 claims. Open Payments data shows 1 records totaling $129. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $507,558 to $3,491,803. Similarly, Part D prescription costs have moved sharply higher in recent years, from $268,152 to $9,607,416. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	513	46,608	$507,558
2016	1,639	169,352	$1,586,863
2017	1,535	118,928	$1,492,524
2018	2,017	335,830	$3,352,965
2019	2,527	513,502	$4,685,248
2020	2,768	462,042	$5,502,977
2021	3,382	547,133	$6,294,866
2022	3,198	570,635	$6,537,490
2023	3,394	408,179	$4,965,023
2024	2,846	280,638	$3,491,803

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	76	214	$268,152
2016	196	651	$645,751
2017	183	856	$743,025
2018	219	1,010	$1,896,856
2019	212	1,061	$3,082,308
2020	217	1,195	$3,272,196
2021	223	1,229	$3,826,621
2022	238	1,427	$5,653,566
2023	282	1,825	$8,204,471
2024	316	2,162	$9,607,416

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	41	$12,388
2018	24	32	$6,073
2019	N/R	36	$1,394
2020	27	30	$2,512
2021	23	76	$6,110
2022	22	107	$15,083
2023	12	213	$50,253
2024	N/R	208	$65,654

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
80053	Blood test, comprehensive group of blood chemicals	1,788	3,579	$10
36415	Insertion of needle into vein for collection of blood sample	1,993	4,222	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	1,961	4,178	$8
83615	Lactate dehydrogenase (enzyme) level	1,409	2,866	$6
84100	Phosphate level	1,474	2,976	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Aranesp	Darbepoetin Alfa In Polysorbat	217	4,704	$736,015
Ibrance	Palbociclib	46	1,288	$698,225
Xtandi	Enzalutamide	46	1,380	$612,186
Calquence	Acalabrutinib Maleate	41	1,230	$598,442
Revlimid	Lenalidomide	22	616	$531,530

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
B4193	Parenteral nutrition solution; compounded amino acid and carbohydrates with electrolytes, trace elements, and vitamins, including preparation, any strength, 52 to 73 grams of protein - premix	N	N/R	52	$47,436
B4185	Parenteral nutrition solution, not otherwise specified, 10 grams lipids	N	N/R	52	$11,402
B4224	Parenteral nutrition administration kit, per day	N	N/R	52	$5,163
B4220	Parenteral nutrition supply kit; premix, per day	N	N/R	52	$1,653

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$129	Intera Oncology, Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Roy Ho Hsin Chen, MD?

Tedicare shows public-source Medicare data for Roy Ho Hsin Chen, MD (NPI 1720248081), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Roy Ho Hsin Chen, MD have ACO affiliation data?

Roy Ho Hsin Chen, MD is shown with ACO affiliation data for ilumed, LLC (REACH, ACO ID D0005) and Vytalize Health 9 ACO LLC (REACH, ACO ID D0313).

What billing organization is linked to Roy Ho Hsin Chen, MD?

Roy Ho Hsin Chen, MD is linked to NORTH SHORE HEMATOLOGY ONCOLOGY ASSOCIATES PC (billing NPI 1396794574) in the available physician profile data.

Does Roy Ho Hsin Chen, MD have Open Payments data?

Roy Ho Hsin Chen, MD has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.